Does SELPERCATINIB Cause Disseminated intravascular coagulation? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Disseminated intravascular coagulation have been filed in association with SELPERCATINIB (RETEVMO). This represents 0.6% of all adverse event reports for SELPERCATINIB.
6
Reports of Disseminated intravascular coagulation with SELPERCATINIB
0.6%
of all SELPERCATINIB reports
1
Deaths
6
Hospitalizations
How Dangerous Is Disseminated intravascular coagulation From SELPERCATINIB?
Of the 6 reports, 1 (16.7%) resulted in death, 6 (100.0%) required hospitalization, and 1 (16.7%) were considered life-threatening.
Is Disseminated intravascular coagulation Listed in the Official Label?
Yes, Disseminated intravascular coagulation is listed as a known adverse reaction in the official FDA drug label for SELPERCATINIB.
What Other Side Effects Does SELPERCATINIB Cause?
Malignant neoplasm progression (106)
Death (90)
Hypertension (58)
Hypersensitivity (55)
Diarrhoea (54)
Fatigue (51)
Rash (49)
Hepatic function abnormal (42)
Alanine aminotransferase increased (38)
Pyrexia (38)
What Other Drugs Cause Disseminated intravascular coagulation?
PREDNISOLONE (362)
METHOTREXATE (347)
DEXAMETHASONE (323)
METHYLPREDNISOLONE (307)
NIVOLUMAB (305)
CYCLOPHOSPHAMIDE (286)
TACROLIMUS (278)
PREDNISONE (277)
VINCRISTINE (245)
OXALIPLATIN (231)
Which SELPERCATINIB Alternatives Have Lower Disseminated intravascular coagulation Risk?
SELPERCATINIB vs SELUMETINIB
SELPERCATINIB vs SEMAGLUTIDE
SELPERCATINIB vs SEMUSTINE
SELPERCATINIB vs SENNA LEAF
SELPERCATINIB vs SENNA LEAF\SENNOSIDES\SENNOSIDES A AND B